• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物通过调控微小RNA治疗结直肠癌。

Natural Products Treat Colorectal Cancer by Regulating miRNA.

作者信息

Guo Shuoxi, Chen Meiqi, Li Shuangyang, Geng Zijun, Jin Ye, Liu Da

机构信息

School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.

出版信息

Pharmaceuticals (Basel). 2023 Aug 9;16(8):1122. doi: 10.3390/ph16081122.

DOI:10.3390/ph16081122
PMID:37631037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10459054/
Abstract

Diseases are evolving as living standards continue to improve. Cancer is the main cause of death and a major public health problem that seriously threatens human life. Colorectal cancer is one of the top ten most common malignant tumors in China, ranking second after gastric cancer among gastrointestinal malignant tumors, and its incidence rate is increasing dramatically each year due to changes in the dietary habits and lifestyle of the world's population. Although conventional therapies, such as surgery, chemotherapy, and radiotherapy, have profoundly impacted the treatment of colorectal cancer (CRC), drug resistance and toxicity remain substantial challenges. Natural products, such as dietary therapeutic agents, are considered the safest alternative for treating CRC. In addition, there is substantial evidence that natural products can induce apoptosis, inhibit cell cycle arrest, and reduce the invasion and migration of colon cancer cells by targeting and regulating the expression and function of miRNAs. Here, we summarize the recent research findings on the miRNA-regulation-based antitumor mechanisms of various active ingredients in natural products, highlighting how natural products target miRNA regulation in colon cancer prevention and treatment. The application of natural drug delivery systems and predictive disease biomarkers in cancer prevention and treatment is also discussed. Such approaches will contribute to the discovery of new regulatory mechanisms associated with disease pathways and provide a new theoretical basis for developing novel colon cancer drugs and compounds and identifying new therapeutic targets.

摘要

随着生活水平的不断提高,疾病也在不断演变。癌症是主要的死因,也是严重威胁人类生命的重大公共卫生问题。结直肠癌是中国十大最常见的恶性肿瘤之一,在胃肠道恶性肿瘤中仅次于胃癌,位居第二,并且由于全球人口饮食习惯和生活方式的改变,其发病率每年都在急剧上升。尽管传统疗法,如手术、化疗和放疗,对结直肠癌(CRC)的治疗产生了深远影响,但耐药性和毒性仍然是巨大的挑战。天然产物,如膳食治疗剂,被认为是治疗CRC最安全的替代品。此外,有大量证据表明,天然产物可以通过靶向和调节miRNA的表达和功能来诱导细胞凋亡、抑制细胞周期停滞,并减少结肠癌细胞的侵袭和迁移。在此,我们总结了天然产物中各种活性成分基于miRNA调控的抗肿瘤机制的最新研究结果,强调了天然产物在结肠癌预防和治疗中如何靶向miRNA调控。还讨论了天然药物递送系统和预测性疾病生物标志物在癌症预防和治疗中的应用。这些方法将有助于发现与疾病途径相关的新调控机制,并为开发新型结肠癌药物和化合物以及确定新的治疗靶点提供新的理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/0174c6833d05/pharmaceuticals-16-01122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/5a85c655a786/pharmaceuticals-16-01122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/24a4e7274169/pharmaceuticals-16-01122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/1e8c5c5bbdfa/pharmaceuticals-16-01122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/0174c6833d05/pharmaceuticals-16-01122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/5a85c655a786/pharmaceuticals-16-01122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/24a4e7274169/pharmaceuticals-16-01122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/1e8c5c5bbdfa/pharmaceuticals-16-01122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea43/10459054/0174c6833d05/pharmaceuticals-16-01122-g004.jpg

相似文献

1
Natural Products Treat Colorectal Cancer by Regulating miRNA.天然产物通过调控微小RNA治疗结直肠癌。
Pharmaceuticals (Basel). 2023 Aug 9;16(8):1122. doi: 10.3390/ph16081122.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
4
Tuberculosis结核病
5
Preclinical Drug Discovery in Colorectal Cancer: A Focus on Natural Compounds.结直肠癌的临床前药物发现:以天然化合物为重点。
Curr Drug Targets. 2021;22(9):977-997. doi: 10.2174/1389450122666210405105206.
6
Natural products for treating colorectal cancer: A mechanistic review.天然产物治疗结直肠癌的作用机制研究进展
Biomed Pharmacother. 2019 Sep;117:109142. doi: 10.1016/j.biopha.2019.109142. Epub 2019 Jun 22.
7
MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.MACC1和CYR61的微小RNA靶点可抑制结直肠癌小鼠的肿瘤生长。
Tumour Biol. 2016 Oct;37(10):13983-13993. doi: 10.1007/s13277-016-5252-2. Epub 2016 Aug 4.
8
Colorectal cancer and therapy response: a focus on the main mechanisms involved.结直肠癌与治疗反应:聚焦于相关主要机制
Front Oncol. 2023 Jul 19;13:1208140. doi: 10.3389/fonc.2023.1208140. eCollection 2023.
9
Colon cancer and colorectal cancer: Prevention and treatment by potential natural products.结肠癌和结直肠癌:潜在天然产物的预防和治疗。
Chem Biol Interact. 2022 Dec 1;368:110170. doi: 10.1016/j.cbi.2022.110170. Epub 2022 Oct 3.
10
Curcumin Targeting Non-Coding RNAs in Colorectal Cancer: Therapeutic and Biomarker Implications.姜黄素靶向结直肠癌中的非编码 RNA:治疗和生物标志物意义。
Biomolecules. 2022 Sep 21;12(10):1339. doi: 10.3390/biom12101339.

引用本文的文献

1
An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update.天然化合物调节结直肠癌表观遗传修饰的潜力概述:最新进展
Epigenetics. 2025 Dec;20(1):2491316. doi: 10.1080/15592294.2025.2491316. Epub 2025 Apr 16.
2
Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer.天然化合物作为微小RNA的调节剂:探索治疗结直肠癌的新途径。
Funct Integr Genomics. 2025 Feb 21;25(1):42. doi: 10.1007/s10142-025-01547-8.
3
Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells.

本文引用的文献

1
Twist1‑mediated transcriptional activation of Claudin‑4 promotes cervical cancer cell migration and invasion.Twist1介导的Claudin-4转录激活促进宫颈癌细胞迁移和侵袭。
Oncol Lett. 2023 Jun 20;26(2):335. doi: 10.3892/ol.2023.13921. eCollection 2023 Aug.
2
A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease.浅析 microRNAs 的生物发生和功能及其在帕金森病神经发病机制中的作用。
Oxid Med Cell Longev. 2023 Jun 8;2023:7759053. doi: 10.1155/2023/7759053. eCollection 2023.
3
Therapeutic Applications of Curcumin and Derivatives in Colorectal Cancer.
利用胆固醇功能化环糊精纳米海绵增强癌细胞中的药物递送
Int J Mol Sci. 2025 Jan 30;26(3):1213. doi: 10.3390/ijms26031213.
4
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma.调节miRNA治疗骨肉瘤的天然产物研究进展
Biology (Basel). 2025 Jan 13;14(1):61. doi: 10.3390/biology14010061.
5
Targeted PHA Microsphere-Loaded Triple-Drug System with Sustained Drug Release for Synergistic Chemotherapy and Gene Therapy.用于协同化疗和基因治疗的靶向负载PHA微球的三联药物系统,具有持续药物释放功能。
Nanomaterials (Basel). 2024 Oct 16;14(20):1657. doi: 10.3390/nano14201657.
6
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.肿瘤干细胞在结直肠癌药物耐药中的作用。
Cancer Control. 2024 Jan-Dec;31:10732748241274196. doi: 10.1177/10732748241274196.
7
Phytocompounds and Nanoformulations for Anticancer Therapy: A Review.植物化合物和纳米制剂在癌症治疗中的应用:综述。
Molecules. 2024 Aug 9;29(16):3784. doi: 10.3390/molecules29163784.
8
Research on lncRNA CTBP1-DT as a potential therapeutic target to regulate cell function in colorectal cancer.长链非编码RNA CTBP1-DT作为调节结直肠癌细胞功能的潜在治疗靶点的研究。
Discov Oncol. 2024 Jun 12;15(1):225. doi: 10.1007/s12672-024-01085-y.
姜黄素及其衍生物在结直肠癌中的治疗应用
Onco Ther. 2022;9(1):51-62. doi: 10.1615/OncoTherap.2022044575.
4
The role of intestinal microbiota and microRNAs in the anti-inflammatory effects of cranberry: from pre-clinical to clinical studies.肠道微生物群和微小RNA在蔓越莓抗炎作用中的作用:从临床前研究到临床研究
Front Nutr. 2023 May 23;10:1092342. doi: 10.3389/fnut.2023.1092342. eCollection 2023.
5
Role of the Dietary Phytochemical Curcumin in Targeting Cancer Cell Signalling Pathways.膳食植物化学物质姜黄素在靶向癌细胞信号通路中的作用。
Plants (Basel). 2023 Apr 26;12(9):1782. doi: 10.3390/plants12091782.
6
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update.将微小RNA及其他非编码RNA作为治疗手段:最新进展
Noncoding RNA. 2023 Apr 13;9(2):27. doi: 10.3390/ncrna9020027.
7
A state-of-the-art review on the MicroRNAs roles in hematopoietic stem cell aging and longevity.关于 MicroRNAs 在造血干细胞衰老和长寿中的作用的最新综述。
Cell Commun Signal. 2023 Apr 24;21(1):85. doi: 10.1186/s12964-023-01117-0.
8
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.靶向结直肠癌耐药性和转移的分子机制:最新进展及展望。
World J Gastroenterol. 2023 Mar 7;29(9):1395-1426. doi: 10.3748/wjg.v29.i9.1395.
9
Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment.白藜芦醇通过 CRC 肿瘤微环境中的β1 整合素/HIF-1α轴调节对 5-FU 的化疗增敏作用。
Int J Mol Sci. 2023 Mar 5;24(5):4988. doi: 10.3390/ijms24054988.
10
Astragaloside IV, as a potential anticancer agent.黄芪甲苷IV,作为一种潜在的抗癌药物。
Front Pharmacol. 2023 Feb 17;14:1065505. doi: 10.3389/fphar.2023.1065505. eCollection 2023.